Go to deals
Healthcare | Industrial Machinery & Components | Private Equity

Sphinx Werkzeuge AG has been acquired by management and Helvetica Capital AG

September 2016 — The owners of Sphinx Werkzeuge AG have sold a majority stake in the company to Helvetica Capital AG and members of the management team. Financial details have not been disclosed.

Sphinx Werkzeuge is a leading precision tools developer and manufacturer for high precision mechanical and medical applications. The company's core business is the production of micro to small drills. In the medical technology industry, its products are mainly used in orthopedic surgery.

Helvetica Capital is a long-term entrepreneurial investor with focus on Swiss SMEs. Jointly with private investors, the firm invests in succession cases of hidden champions to sustainably develop them.

In the course of a succession plan, Sphinx Werkzeuge's management team and other investors decided to sell a majority shareholding to Helvetica Capital AG. With this transaction, the company has found the right partner for its long-term development. Sphinx Werkzeuge will continue under its existing name, management and staff.

Long-term shareholder and former member of Sphinx Werkzeuge's management team Bruno Fellmann, who will leave the company, commented: "Speaking on behalf of all shareholders, I am glad that we found the ideal solution for the company. With Helvetica Capital as the new owner, we are confident that Sphinx Werkzeuge will continue on its successful path as a stand-alone company."

Our role in the transaction

Oaklins' team in Switzerland advised the shareholders on the preparation of the succession process and due diligence, the approach and negotiations with potential buyers, and assisted them until closing.

Parties

Talk to the deal team

Dr. Jürg Stucker

Partner
Zurich, Switzerland
Oaklins Switzerland

Dr. Daniel Spring

Partner
Bern, Switzerland
Oaklins Switzerland

Related deals

Cibus has acquired Aweta from Standard Investment
Private Equity | Agriculture | Industrial Machinery & Components

Cibus has acquired Aweta from Standard Investment

Standard Investment has reached an agreement with Cibus Capital, advisor to the Cibus funds, on the sale of Aweta, a global leader in fruit and vegetable sorting, grading and packing equipment. Completion of the transaction is expected in the coming weeks. The transaction provides Aweta with a strong partner to support the company’s next growth phase. Under Cibus’ ownership, Aweta will pursue further international growth and accelerate investment in R&D, supporting the installed base and product innovation, including software and AI capabilities. Aweta’s leadership team will continue to lead the business.

Learn more
Comtax has been acquired by Ryan
Private Equity | Business Support Services | TMT

Comtax has been acquired by Ryan

Comtax, a São Paulo-based tax technology consultancy specializing in tax determination and digital tax compliance, had been acquired by Ryan, the world’s largest firm dedicated exclusively to business taxes. The transaction marks Ryan’s entry into the Brazilian market, adding a specialized team and an established base of large corporate clients in Brazil, one of the world’s most complex tax environments, at a time when the country’s consumption tax reform is set to reshape how companies calculate and report indirect taxes. For Comtax, the acquisition brings access to Ryan’s global platform, technology and client network across more than 80 countries, creating opportunities to scale its tax determination and compliance offering beyond its current footprint. Comtax’s founders will continue to lead the business.

Learn more
Katalyst Diagnostics has been acquired by Cruinn Diagnostics
Healthcare

Katalyst Diagnostics has been acquired by Cruinn Diagnostics

Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.

Learn more